Cats have been shown to be infected with Bartonella henselae genotype I, B. henselae genotype II, and B. clarridgeiae. Feline bartonellosis infections and the strains involved in these infections are important in both veterinary and human medicine. Nucleic acid amplification methods such as polymerase chain reaction (PCR) are being used in both research and diagnostics as tools for understanding many infectious diseases. Bartonella bacteremia in cats is detected by blood culture; however, because of the limitations of culture (delayed turnaround time and sensitivity limits), PCR may be a more efficient method for identifying infected cats. Three distinct PCR assays that could differentiate among B. henselae genotype I, B. henselae genotype II, and B. clarridgeiae were developed and used to detect as few as 3.2 organisms. Fourteen cats experimentally infected with B. henselae genotype I and B. henselae genotype II were followed by bacterial culture and PCR through the course of infection, including periods of primary and relapsing bacteremia. The PCR assay was positive in 11 of the 14 cats for periods of 1-9 weeks after culture became negative. Of the 223 blood specimens that were culture negative, the PCR assay was positive in 38 (17%) of the specimens. Two of the 14 cats developed relapsing bacteremia. The 2 B. henselae genotypes were amplified in the cats and the bacteremic phase of these infections as determined by PCR lasted for a longer period than previously determined by culture. Using laboratory assays such as PCR to understand the strains involved in feline bartonellosis and the course of the infection is important in the understanding of these zoonotic agents.
The importance of Bartonella henselae as an emerging pathogen is recognized more each day by veterinarians, cat owners, and physicians. Bartonella henselae causes a wide spectrum of diseases and diverse pathology in humans, and the domestic cat has been shown to be the reservoir for several Bartonella species. 1, 5, 6, 13 Diseases in humans primarily depend on the immune status of the patient. Cat scratch disease, the most common syndrome caused by B. henselae in immunocompetent patients, is usually a localized selflimiting disease that resolves in time. Sequela to cat scratch disease occurs in 14% of cases and manifests in serious clinical conditions. 24 Unusual manifestations that have been reported include cases of encephalitis, retinitis, conjunctivitis, hepatic granulomas, osteomyelitis, pulmonary disease, and endocarditis. 24 Bacillary angiomatosis and bacillary peliosis, caused by B. henselae in immunocompromised patients, involve multiple organs and are serious life-threatening diseases. Bartonella henselae has been shown to establish per-sistent infection in humans, displayed as a bacteremia and endocarditis. 26 The domestic cat population in the USA numbers approximately 60 million, and 15-25 million cats may be infected with B. henselae. 19 In the USA, Bartonella seroprevalence varies and is as high as 65.4% in some regions. 6, 12 Bartonella henselae genotype I, B. henselae genotype II, and B. clarridgeiae have been isolated from cats and are also associated with human disease. 27 Bartonella clarridgeiae infections in cats are less common, with isolation rates reported to be approximately 10% in certain regions. 17, 20 Clinical disease in cats experimentally infected with Bartonella species varies and is thought to be strain related. 26 In several studies, isolation of B. henselae genotype II from cats was more common than isolation of B. henselae genotype I. 8, 28 Some cats are coinfected with B. henselae and B. clarridgeiae or B. henselae genotypes I and II. 9 It is not known if there is a difference in virulence or pathogenicity associated with the various species or genotypes of Bartonella in cats. Identifying and characterizing the strains or genotypes of B. henselae would be useful in studies of the pathogenesis of feline bartonellosis.
Given the endemicity of Bartonella infection in cats, an understanding of feline bartonellosis is important to those involved in veterinary medicine and human medicine. Because cats can be persistently and asymp-tomatically infected with B. henselae, with intermittent bacteremia, recognizing and understanding feline bartonellosis is important. 19, 23 The bacteremia seen in B. henselae infection in cats can be of significant magnitude in acute or chronic infection. 15 The likelihood of transmission of B. henselae from cats to humans is thought to be highest during times when cats are bacteremic. 22 The pathogenesis of B. henselae in the cat is not understood. Assays currently available to identify cats infected with Bartonella species include bacterial culture, serologic assay, nucleic acid amplification methods, and Warthin-Starry silver stain. Bacterial culture for Bartonella species is not ideal and can be limited because of the fastidious nature of organism, the time required for isolation, and the detection limits of culture. 4 The limitations of culture have been demonstrated by amplification of Bartonella DNA from the blood of culture-negative cats. 16 The discovery of Bartonella as the etiologic agent associated with cat scratch disease, and bacillary angiomatosis, was first made with PCR assays, and these assays continue to be a useful laboratory tool for diagnosing these infections. 25 There are numerous reports of diagnosis of Bartonella infections in humans in which blood and organ cultures were negative but B. henselae DNA was amplified from tissue. 11, 28, 29, 31 A PCR assay for the identification of species and genotypes would assist in characterization of the various strains involved in feline bartonellosis. The purpose of this study was to develop a tool that could be used to detect Bartonella in numbers below the limits of culture and to differentiate the various Bartonella species and genotypes. In this study, a nested PCR was developed using the 16S ribosomal RNA (rRNA) gene of Bartonella species. This assay is sensitive and is genus, species, and genotype specific. Blood from experimentally infected cats was cultured and assayed by PCR during the acute and chronic phases of the infection. The application of PCR will assist in the understanding of the pathogenesis of Bartonella species in the cat populations. Experimental animals and infections. All the cats used in these studies were part of larger studies looking at the immunologic parameters associated with B. henselae. Specificpathogen-free (SPF) cats (n ϭ 16) that were culture negative for B. henselae and antibody negative by western blot analysis were used in this study. 7 Twelve cats, purchased from commercial vendors (n ϭ 9 d , p ϭ 3 e ), were inoculated intradermally (ID) with 0.6 ml, divided among 6 sites on the lateral aspect of the trunk, of 1 ϫ 10 7 colony-forming units (CFU) strain B. henselae Houston-1 genotype I (n ϭ 3), 1 ϫ 10 7 CFU of strain B. henselae 87-66 genotype I (n ϭ 3), 1 ϫ 10 7 CFU of strain B. henselae LSU16 genotype II (n ϭ 3), or 1 ϫ 10 9 CFU of strain B. henselae LSU Baby genotype II (n ϭ 3).
Materials and methods
Four cats (nos. 10, 83, 86, 87) bred at Louisiana State University were also enrolled in this study at various stages during their infection. All 4 cats had received 60 ml of cat serum containing anti-B. henselae LSU16 genotype II antibodies immediately prior to challenge with 0.3 ml of 1 ϫ 10 6 CFU of strain B. henselae LSU16 genotype II ID divided among 3 sites. Eleven weeks later, these cats were challenged again with 1 ϫ 10 6 CFU of strain B. henselae LSU16 genotype II. These cats entered this study 3 wk after the second challenge. Thirteen weeks after the second challenge, 2 of these cats (nos. 86 and 87) were given 4 injections of 10 mg/kg methylprednisolone f intramuscularly at 2-wk intervals (Brown TP, et al.: 1999, Abstr Conf Res Workers Anim Dis #4).
Collection of blood specimens. Peripheral blood was collected weekly beginning 1 wk after inoculation and until the time of necropsy. A total of 362 blood specimens were collected in the study. Before each collection, cats were anesthetized with tiletamine zolazepam g at the recommended dosage. Blood was collected aseptically by jugular puncture and placed in Vacutainer tubes h containing ethylenediaminetetraacetic acid (EDTA) for PCR assay and in pediatric lysis-centrifugation isolator tubes i for culture. Blood collected in EDTA tubes was frozen at Ϫ20 C overnight, and DNA extractions were performed the next day followed by PCR assay.
Blood cultures. Blood cultures were performed on blood collected in pediatric lysis-centrifugation tubes. A 10-l aliquot of blood was removed from the tube and serially diluted. Dilutions (30 l) were inoculated onto chocolate agar and incubated at 37 C in 5% CO 2 for 7 days. Colony counts were recorded as CFU per milliliter of blood. Isolates were confirmed to have phenotypic characteristics consistent with B. henselae.
Defining bacteremia. Bacteremia in experimentally infected cats was determined by isolation of Bartonella from a blood specimen (culture positive) or amplification of Bartonella DNA from a blood specimen (PCR positive).
Extraction of DNA from whole blood specimens. DNA was extracted from 200 l of whole blood collected in EDTA vacutainer tubes using a commercial kit according to manufacturer's instructions. j Extraction of DNA from bacterial strains. Approximately 10 colonies of each bacterial isolate were taken from the agar with an inoculating loop, placed into 2 ml of phosphatebuffered saline (PBS), vortexed, and centrifuged. DNA extraction was performed using a commercial kit according to manufacturer's instructions. j Extraction controls. Controls included all reagents without a DNA sample and were processed exactly as described above to ensure that extraction buffers and reagents were not contaminated with target DNA. Blood from negative cats was periodically extracted as a contamination control. Blood from positive cats was periodically extracted as a positive control.
Bartonella genus-, species-, and type-specific oligonucleotide primers for PCR. The target gene chosen for amplifi-cation was the 16S rRNA gene of Bartonella. By identifying conserved and hypervariable regions within the 16S rRNA gene, primers that are genus specific, species specific, and type specific were designed. The primer sequences with the nucleotide positions are shown in Table 1 . The primer sets with each PCR product size for Bartonella genus, species, and genotype are shown in Table 2 . The synthetic oligonucleotides were purchased from a commercial source. k For the nested reaction, PCR primers were used in a primary reaction and a subsequent second reaction to amplify a region internal to the previous priming site. The Bartonella genusspecific forward primer Bhen16SFF was used in combination with reverse primer UB16SDR9 to amplify an 823-bp fragment. In a second reaction forward primer Bhen16SFF was used in combination with the inner reverse primer Bhen16SBBR to generate a 567-bp Bartonella genus-specific fragment. The species-and type-specific Bartonella nested PCR was done with combinations of the outer primers Bhen16SFF/UB16SDR9 and the second reaction inner primers Bhen16SGG, Bhen16SHH, Bhen16SCC, and Bhen16SBBR.
PCR amplification of DNA. PCR amplification was performed in a final volume of 50 l by using a reaction mixture containing deoxynucleoside triphosphates (200 M each), 1.75 mM MgCl 2 , 0.2 M of each primer 2.5 U of Taq DNA polymerase, l 4 l of DNA template, and 32.6 l of buffer. l The PCR amplifications were carried out on a Model 9600 thermalcycler. l Amplification reaction consisted of 10 min at 95 C, 30 cycles of 94 C for 1 min, 66 C for 1 min, and 72 C for 1 min and a final elongation step of 72 C for 10 min. A second amplification reaction of 20 cycles with the sample conditions as previously stated was performed using inner primers and 1 l of DNA from the first PCR reaction. As a negative control, PCR reagents without DNA template were included in each amplification assay. Positive controls of extracted Bartonella species were also used in each amplification assay.
Detection of PCR products. The PCR-amplified products were detected by electrophoresis on a 2% agarose gel in Tris-borate-EDTA buffer and visualized with ethidium bromide and ultraviolet light transillumination. Sixteen microliters of the final product was analyzed in each lane of the gel. A molecular marker m with 6 bluntend DNA fragments of 2,000, 1,200, 800, 400, 200, and 100 bp was used to identify fragment sizes.
Sensitivity of PCR. To determine the minimum amount of Bartonella DNA that could be detected by this PCR assay specific for the 16S rRNA gene of B. henselae, genomic Bartonella DNA was extracted from a B. henselae culture using a protocol for bacteria from a commercial kit. j The total DNA extracted from culture was measured by absorbance at 260 nm on a spectrophotometer n using the Warburg-Christian concentration method. 30 Serial 10-fold dilutions of the extracted DNA were made in the elution buffer from the commercial kit, j and PCR amplification was performed on each dilution. To determine the minimum number of organisms that could be detected by PCR assay of the 16S rRNA gene of B. henselae, serial dilutions of B. henselae organisms diluted in PBS and B. henselae diluted in sterile cat blood were prepared. Each dilution was extracted using the commercial kit j according to manufacturer's directions, and PCR amplification was performed. A quantitative 
Results
Specificity of the nested PCR. The primer pair Bhen16SFF/Bhen16SDR9 amplified the predicted products of 823 bp in the first amplification from each of the Bartonella species (Fig. 1A) . The primer pair Bhen16SFF/Bhen16SBBR amplified the 567-bp DNA in the second amplification of PCR with DNA templates from each of the Bartonella species except B. elizabethae (Fig. 1B) Sensitivity of B. henselae nested PCR. The sensitivity limit of the assay was determined as the minimum amount of genomic DNA from an isolate of B. henselae and minimum number of B. henselae organisms in spiked cat blood that could be detected. The sensitivity limits of B. henselae genomic DNA of the first reaction with primers Bhen16SFF/Bhen16SDR9 was approximately 6.4 pg or 3.2 ϫ 10 3 organism ( Fig. 2A) . By using the nested PCR, the sensitivity limits of the Nested PCR for Bartonella henselae in cats 
3.4 ϫ 10 5 3.5 ϫ 10 4 3.6 ϫ 10 5 70 ϫ 10 2 1.0 ϫ 10 2 1.0 ϫ 10 2 1.5 ϫ 10 2 0 0 assay were increased to approximately 6.4 fg, which corresponds to 3.2 organisms (Fig. 2B) . To estimate the quantity of genomic DNA in 1 cell of Bartonella, the molecular mass of Bartonella bacilliformis (1.76 ϫ 10 Ϫ15 g or 1.7 fg; 1.6 ϫ 10 6 bp ϭ 1.7 fg) was used. Applying this method of estimation, 1 Bartonella cell (2 ϫ 10 6 bp) is equal to approximately 2 fg. This assay was repeated 3 times. Using 200 l of each dilution of B. henselae in sterile cat blood, the sensitivity limits of B. henselae in cat blood was determined to be 1 10-fold dilution beyond the minimal detection limit of culture of 25 CFU/ ml. This assay was repeated 3 times. The nested PCR enhanced detection of organisms from the blood of cats experimentally infected with B. henselae. The limit of detection in cat 87, when using primer set Bhen16FF/UB162DR9 in the first reaction, was 19,000 CFU/ml. In the first reaction using primer set Bhen 16FF/UB162DR9, the assay did not detect amplicons in the blood of cats when the culture results were 1,400 CFU/ml, 1,200 CFU/ml, or 300 CFU/ml. In the second reaction using the inner primers Bhen16SFF and Bhen16SBBR, the nested PCR assay detected amplicons of B. henselae in cat 87 below the limits of culture at 1,400 CFU/ml, 1,200 CFU/ml, 300 CFU/ml, and when the culture was negative for 2 consecutive weeks.
Bacteremia in experimentally infected cats. In this study, cats experimentally infected with B. henselae were followed by PCR and culture beginning 1 week after inoculation and until time of necropsy. Over the course of this study, 362 blood specimens were used to investigate the bacteremic phase of the infection using PCR assay and bacterial culture. Fourteen of the 16 cats experimentally inoculated became bacteremic within 1-2 weeks postinoculation ( Table 3 ). Two of the cats (F5 and 347) inoculated with B. henselae Houston-1 did not become bacteremic during the study (Table 3 ). Bacteremia in the cats ranged from 1.0 ϫ 10 2 to 8.0 ϫ 10 5 CFU/ml. The duration of the bacteremia ranged from 5 to 22 weeks. Bacteremia was determined by isolation of Bartonella from blood or amplification of Bartonella DNA from blood. In most samples, the PCR was useful in detecting Bartonella DNA after the culture became negative. The PCR assays were positive in 11 of the 14 cats for periods of 1-9 weeks after culture became negative.
Relapsing bacteremia. Two cats, nos 86 and 321, 
infected with B. henselae LSU16, a pathogenic strain of Bartonella in cats, had an episode of relapsing bacteremia (Table 3) . Cat 86 experienced a culture-negative interval of 7 weeks between the 2 episodes of bacteremia. The second bacteremia in cat 86 lasted for 8 weeks before the blood culture became negative. The PCR assay in cat 86 was positive for 2 weeks longer than the culture in the first episode of bacteremia. During the second bacteremia, both culture and PCR were positive from week 13 through week 20. Cat 321 was PCR and culture positive from week 1 through week 6. At week 7, the PCR was positive and the culture was negative. At week 8, both assays were positive again for 3 weeks. After an 11-week culture-negative interval, cat 321 became culture and PCR positive again. The second episode of bacteremia in cat 321 lasted for 4 weeks, with positive culture results for 4 weeks and positive PCR results for only 3 of those weeks. Results of the PCR assay were comparable to culture results in most of the specimens. The PCR assay was positive in 135 of the 140 (96%) blood specimens that were culture positive ( Table 4 ). The PCR assay was negative for 3 blood specimens of cat L3 and cat 321 that were culture positive with 100 CFU/ ml. Of the 223 blood specimens that were culture negative, PCR assay was positive in 38 (17%) of these specimens (Table 4 ).
Sequence analysis. The sequence data derived from B. henselae LSU16 and B. henselae LSU Baby were that of a B. henselae genotype II strain, with the bases ATT located between positions 172-175 of the 16S rRNA gene identical to previous descriptions of B. henselae genotype II. 2 The sequence data from B. henselae Houston-1 and B. henselae 87-66 located between positions 172-175 of the 16S rRNA gene were that of a B. henselae genotype I with the bases TAG as previously described (Fig. 3) . The sequence data derived from the blood of cat 86 indicated a B. henselae genotype II with the bases ATT (Fig. 3) . The sequence data from the isolate of B. clarridgeiae was as reported, with bases ACT located between positions 172-175 of the 16S rRNA gene (GenBank accession no. X97822) (Fig. 3) .
Discussion
A PCR assay that is both sensitive and specific is a good tool for detecting etiologic agents involved in persistent bacteremia in which the numbers of organ-Nested PCR for Bartonella henselae in cats 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28 29 isms are low or the organisms are fastidious or slow growing. In this study, the results of the PCR assay agreed with those of culture in the majority of the specimens but allowed detection of Bartonella DNA in the experimentally infected cats when the culture was negative. The sensitivity limits of this assay were determined using genomic DNA (Bartonella) and sterile cat blood spiked with Bartonella. To increase the sensitivity limits of the assay further, a nested PCR design was used. Using genomic DNA, the nested PCR lowered the detection limits of the assay from 3.4 ϫ 10 4 organisms to 3.2 organism, and in spiked cat blood the detection limits of PCR were below the detection limits of culture.
The primers designed in this assay were Bartonella genus, species, and genotype specific. The assay was specific for B. henselae genotypes I and II and B. clarridgeiae, all of which have been isolated from cats and are associated with cat scratch fever in humans. Two other Bartonella species, B. quintana and B. elizabethae, were also detected using the primer set Bhen16SFF/UB16SDR9 in the first reaction of the PCR. However, in the nested PCR design in the second reaction, B. elizabethae was not amplified because the reverse primer Bhen16SBBR was specific to the gene fragment of B. elizabethae.
The performance of the PCR assay was evaluated in cats experimentally inoculated with multiple strains of B. henselae. The PCR was able to detect cats experimentally infected with B. henselae genotypes I and II as expected. The ability of the PCR to detect bloodculture-positive cats was seen in the majority of specimens. The PCR was positive in all culture-positive cats with the exception of 3 specimens. For unknown reasons, the PCR assay missed 3 blood specimens that were culture positive with 100 CFU/ml. The cohesion and aggregation factors that have been reported with Bartonella species may have played a role in this misidentification. Bartonella henselae and B. clarridgeiae display a degree of cohesiveness and this has been correlated with cells existing in a tightly packed array (Clarridge JE: 1996, Am Soc Microbiol Gen Meet, p. 73). Despite the fact that the blood was vortexed before sampling, the PCR could have been negative because of the coherent nature of the organism. Although the PCR missed 3 culture-positive specimens, comparing the turnaround time of PCR to culture (24 hours to 1-2 weeks, respectively), the PCR would have an advantage over culture.
The sensitivity of detection of B. henselae from blood is improved by lysis of host cell either by collection of blood in lysis-centrifugation tubes or by freezing of blood collected in EDTA. 3 In this study, cat blood was lysed before use for culture and PCR assay, which may have added to the recovery of organisms. Blood was collected in lysis-centrifugation tubes for culture and in tubes containing EDTA with subsequent freezing for PCR assay. Whether B. henselae is an extracellular or intracellular organism is not completely understood. Several studies have shown an intraerythrocytic location of B. henselae in infected cats, 14, 21 whereas another study showed only an extracellular location. 8 If there is an intracellular location of B. henselae in erythrocytes or neutrophils, lysis of blood as done in this study would only increase the sensitivity limits of both culture and PCR. The nested PCR assay was able to detect Bartonella DNA in circulating blood of 38 experimentally infected cats that were culture negative. This can be explained by the difference in sensitivity between PCR and culture as shown when equal volumes of cat blood (200 l) spiked with Bartonella were used to compare the PCR and culture detection limits. In theory, this nested PCR can detect approximately 3.2 Bartonella organisms. However, in the experimentally infected cats there was a difference in volume of blood used in the PCR assay (200 l) and that used in culture (10 l), which may partially explain the disparity in results between PCR and culture.
In the majority of specimens tested, the PCR results remained positive from 1 to 9 weeks after the culture became negative. The performance of the PCR assay was such that in several cases the PCR was positive for 1 week when the culture became negative or the PCR was negative for 1 week followed by a positive result the next week. These results may reflect a time when the bacteremia was waning and the number of organisms was below the minimum detection limits of culture or may represent a false-positive PCR result.
The higher number of positive PCR compared with positive culture results could be explained by existence of circulating nonviable organisms or Bartonella DNA. Although the amplification of Bartonella DNA from the blood of Bartonella-infected cats may represent dead bacteria, the detection of Bartonella DNA in some cats as long as 9 weeks after blood cultures were negative makes the detection of dead bacteria unlikely. Rather, amplification of Bartonella DNA in the blood of infected cats long after the blood culture is negative may represent a small number of viable organisms circulating in the peripheral blood. Also, Bartonella DNA in the blood of these cats may be due to the shedding of microorganisms into the peripheral blood from a sequestered location, such as the endothelial cells of the vascular system. If bacteremia is defined by a positive culture or PCR, the findings of the present study suggest that the duration in cats of bacteremia caused by B. henselae may be longer if methods other than culture are used for detection. The question then centers on the infectious nature of bartonellosis in cats in this stage of the infection. Bartonella henselae has been transmitted from a blood-culture-negative cat by inoculation of blood into a SPF cat. 18 This observation indicates that a negative blood culture cannot be used to definitively rule out Bartonella infection in cats. If cats are infectious after the culture is negative and PCR is positive, the PCR assay would be a more accurate laboratory assay for detecting cats with Bartonella infection.
The PCR assay did not detect Bartonella DNA ear-lier than did blood culture in the cats with a recurrent episode of bacteremia or in cats with primary infection. If blood had been taken within 1 week before the primary or recurrent episode, a positive result for Bartonella DNA may have been obtained by PCR. It is not known how the organisms seed the blood in these infections. If the organism slowly leaks into the circulating blood from a source such as the endothelial lining, the PCR results may be positive before the culture results. If the organism seeds the blood suddenly with a number of organisms large enough for the culture to be positive, the PCR assay would not be positive any sooner than culture. However, because of the turnaround time of the PCR assay as compared with culture, the infection of a cat with Bartonella would be noted at an earlier time. All 4 strains of B. henselae were sequenced for confirmation of B. henselae genotypes used in the experimental infections. PCR products from cat 86 infected with B. henselae LSU16 were sequenced for verification of PCR products amplified from cats. Sequence analysis was performed to confirm that the primers designed for each particular genotype of B. henselae were specific.
Molecular assays such as PCR give a higher discriminatory power in identification of microorganisms than does identification by phenotypic characteristics only. 25 The products amplified in this PCR assay were confirmed by sequence analysis, which is a based on genetic information rather than phenotypic tests, as in culture methods. In addition, molecular assays such as PCR that will amplify and allow for detection of microorganisms missed because of the insensitivity of a particular method is a powerful tool in research and clinical microbiology. This PCR assay is both sensitive and specific and will be used in our laboratory for further studies for the understanding of the pathogenesis of B. henselae in cats.
